Myoptechs
Columbus, US · Founded 2022 · Delaware corporation · 2 known investors
Myoptechs develops treatments and interventions for myopia, a progressive eye disease that causes worsening distance vision and can lead to sight-threatening complications. The company targets patients and their eye care providers seeking to reduce both short- and long-term vision complications from myopia.
Founders & leadership
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$1.3MraisedSep 2024 · 7 investors · Other Health CareRule 506(b)
▶$1.3MraisedSep 2024 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robin SearsDirector
- Wayne EmbreeDirector
- Paul GrimmExecutive Officer, Director
- Brad BeaseckerExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Myoptechs has filed a notice of an exempt offering of securities to raise $2,000,000.00 in New Equity Investment. - intelligence360intelligence360.news · 2024
- Myoptechs raises USD 2 million - Medical Buyermedicalbuyer.co.in · 2024
- Myoptechs Announces $2.0 Million Fundraise and Provides Update on Clinical Development Programprnewswire.com · 2024
- Columbus Startup Myoptechs Develops Specialty Contact Lenses for Nearsighted Childrencolumbusceo.com · 2024


